Drugmakers can't charge beyond making costs for compassionate use: FDA

June 3, 2016 12:15 PM

15 0

Drugmakers can't charge beyond making costs for compassionate use: FDA

The U.S. Food and Drug Administration said companies could only charge patients for the cost of manufacturing experimental treatments used under compassionate grounds, and it cannot force government or private health insurers to pay for these drugs.

"Compassionate use" of experimental drugs allows physicians to prescribe unapproved treatments for patients who have no other satisfactory alternatives in the market.

Read more

To category page

Loading...